Literature DB >> 1582583

Epidermal growth factor receptors in the oesophagus.

J Jankowski1, S Murphy, G Coghill, A Grant, K G Wormsley, D S Sanders, M Kerr, D Hopwood.   

Abstract

The quantity and distribution of epidermal growth factor receptors (EGF-R) in oesophageal mucosa was studied in the oesophagus in order to determine its role in oesophageal disease. Fifty five biopsies were taken from different levels of the oesophagus in 25 consecutive patients undergoing endoscopy. Another group of eight patients with histologically proven Barrett's oesophagitis had a biopsy taken from the area of columnar lined oesophagus. A peripheral, membranous pattern was seen predominantly confined to the basal and immediately suprabasal cells in all of the first group of patients. In the superficial cells a few granular cytoplasmic structures were positive. All patients with Barrett's oesophagitis showed EGF-R staining of the surface epithelium. A computerised planimeter was used to determine the proportion of stained areas of squamous cells which were expressed as a percentage of the total area of squamous cells. The difference in the area of cells stained for EGF-R between normal and inflamed oesophageal mucosa (29.5% and 43.1% respectively) was significant (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582583      PMCID: PMC1374055          DOI: 10.1136/gut.33.4.439

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.

Authors:  S Massoglia; A Gray; T J Dull; S Munemitsu; H J Kun; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 3.  Structure, function and transforming potential of the epidermal growth factor receptor.

Authors:  T J Velu
Journal:  Mol Cell Endocrinol       Date:  1990-05-07       Impact factor: 4.102

4.  Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma.

Authors:  H Sakai; K Kawano; K Okamura; N Hashimoto
Journal:  J Oral Pathol Med       Date:  1990-01       Impact factor: 4.253

5.  The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.

Authors:  P P Di Fiore; O Segatto; F Lonardo; F Fazioli; J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor.

Authors:  P J Parker; S Young; W J Gullick; E L Mayes; P Bennett; M D Waterfield
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

7.  EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors.

Authors:  K Yoshida; E Kyo; T Tsuda; T Tsujino; M Ito; M Niimoto; E Tahara
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

8.  Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

Authors:  P Anklesaria; J Teixidó; M Laiho; J H Pierce; J S Greenberger; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Hydrochloric acid. A trigger of cell proliferation in the esophagus of dogs.

Authors:  A De Backer; P Haentjens; G Willems
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

10.  Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.

Authors:  M Toi; T Nakamura; H Mukaida; T Wada; A Osaki; H Yamada; T Toge; M Niimoto; T Hattori
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

View more
  24 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 3.  Barrett's esophagus: environmental influences in the progression of dysplasia.

Authors:  Ralph A Boulton; Bernhard Usselmann; Imtiyaz Mohammed; Janusz Jankowski
Journal:  World J Surg       Date:  2003-07-28       Impact factor: 3.352

Review 4.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

5.  Dynamic change of epidermal growth factor in neonatal rat with intestine injury.

Authors:  Hui Lu; Jun Li; Li-Li Pan; Xin-Dong Xue
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 6.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

7.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

8.  Epidermal growth factor in saliva and gastric juice: response to histamine.

Authors:  A M Tunio; M Hobsley
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR).

Authors:  Nelly E Avissar; Liana Toia; Yingchuan Hu; Thomas J Watson; Carolyn Jones; Daniel P Raymond; Alexi Matousek; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2008-10-15       Impact factor: 3.452

10.  Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs.

Authors:  C O Juhl; L Vinter-Jensen; L S Jensen; E Nexø; J C Djurhuus; E Z Dajani
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.